In agreement with our findings, other studies have also demonstrated the increased RTN4 levels in the chronic active demyelinating lesions of brain tissues, cerebrospinal fluid, and blood patients with multiple sclerosis [25,26,27,28]. This evidence concerns the gene RTN4 and multiple sclerosis.